HIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-line.

Hdl Handle:
http://hdl.handle.net/10144/619319
Title:
HIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-line.
Authors:
Fily, F; Ayikobua, E; Ssemwanga, D; Nicholas, S; Kaleebu, P; Delaugerre, C; Pasquier, E; Amoros Quiles, I; Balkan, S; Schramm, B
Journal:
Tropical Medicine & International Health
Abstract:
The number of patients on second-line antiretroviral therapy is growing, but data on HIV drug resistance patterns at failure in resource-constrained settings are scarce. We aimed to describe drug resistance and investigate the factors associated with extensive resistance to nucleoside/nucleotide reverse transcriptase inhibitors (NRTI), in patients failing second-line therapy in the HIV outpatient clinic at Arua Regional Referral Hospital, Uganda.
Publisher:
Wiley-Blackwell
Issue Date:
29-Jul-2018
URI:
http://hdl.handle.net/10144/619319
DOI:
10.1111/tmi.13131
PubMed ID:
30058269
Submitted date:
2018-08-07
Language:
en
ISSN:
1365-3156
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorFily, Fen
dc.contributor.authorAyikobua, Een
dc.contributor.authorSsemwanga, Den
dc.contributor.authorNicholas, Sen
dc.contributor.authorKaleebu, Pen
dc.contributor.authorDelaugerre, Cen
dc.contributor.authorPasquier, Een
dc.contributor.authorAmoros Quiles, Ien
dc.contributor.authorBalkan, Sen
dc.contributor.authorSchramm, Ben
dc.date.accessioned2018-12-10T08:26:39Z-
dc.date.available2018-12-10T08:26:39Z-
dc.date.issued2018-07-29-
dc.date.submitted2018-08-07-
dc.identifier.citationHIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-line. 2018 Trop. Med. Int. Healthen
dc.identifier.issn1365-3156-
dc.identifier.pmid30058269-
dc.identifier.doi10.1111/tmi.13131-
dc.identifier.urihttp://hdl.handle.net/10144/619319-
dc.description.abstractThe number of patients on second-line antiretroviral therapy is growing, but data on HIV drug resistance patterns at failure in resource-constrained settings are scarce. We aimed to describe drug resistance and investigate the factors associated with extensive resistance to nucleoside/nucleotide reverse transcriptase inhibitors (NRTI), in patients failing second-line therapy in the HIV outpatient clinic at Arua Regional Referral Hospital, Uganda.en
dc.language.isoenen
dc.publisherWiley-Blackwellen
dc.rightsArchived on this site with the kind permission of Wiley-Blackwell.en
dc.titleHIV-1 drug resistance testing at second-line regimen failure in Arua, Uganda: avoiding unnecessary switch to an empiric third-line.en
dc.identifier.journalTropical Medicine & International Healthen

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.